Philipp Tropberger
Senior Principal Scientist Novartis AG
Seminars
Wednesday 2nd December 2026
Fireside Discussion: Celebrating 10 Years of Antifibrotic Drug Development: Reflecting on the Past to Shape the Next Decade
8:30 am
- Examining the evolution of antifibrotic drug development over the past decade, including scientific advances, regulatory progress, and persistent challenges
- Discussing lessons learned from clinical successes & failures that can inform future development strategies
- Envisioning the next decade: breakthrough opportunities in fibrosis resolution, precision medicine, and cross-indication therapeutic development
Wednesday 2nd December 2026
Achieving Cell-Selective Delivery to Maximize Efficacy & Minimize Systemic Toxicity
9:30 am
- Design principles for targeted delivery approaches
- Leveraging fibroblast-selective targeting to concentrate drug exposure in target cells/tissue
- Balancing the complexity of targeted delivery with the therapeutic benefit & competitive differentiation
